Pharmafile Logo
Pharmafocus logo
Advanced Search
takeda_tokyo_hq

Takeda lays off more than half of Ariad’s US staff

March 31, 2017
Medical Communications Ariad Pharmaceuticals, Takeda

Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …

News

FDA approves first-ever atopic dermatitis biologic treatment

March 31, 2017
Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic

Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …

News
astrazeneca_sign_sky

AstraZeneca ends month with two pieces of news

March 31, 2017
Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex

AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …

News
d2wtepzz

Changing levels of investment in UK drug discovery

March 31, 2017
Medical Communications, Research and Development ABPI, drug discovery, report

Key drug discovery investment trends

News
carb-x-interior-header

US and UK partnership to fund the fight against superbugs

March 31, 2017
Medical Communications, Research and Development CARB-X, Wellcome Trust

The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …

News
giles_platford

Takeda names new President of Europe and Canada Business Unit

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …

Appointment
paul-catchpole

Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system

March 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …

Feature
fda2outsideweb

Trump’s FDA pick vows to sever past pharma ties to avoid partisanship

March 30, 2017
Medical Communications, Sales and Marketing FDA, Scott Gottlieb, Trump

After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

News

Mylan’s generic of best-selling GSK drug delayed by FDA

March 30, 2017
Sales and Marketing Advair, GSK, Mylan

Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …

News
roche_close

First treatment for form of MS approved by FDA

March 30, 2017
Sales and Marketing Biogen, Genentech, MS, Roche

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …

News
novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017
Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

News
nhs_bands

Women are 77% of NHS workforce but occupy only 41% board positions

March 29, 2017
Medical Communications NHS

A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …

News
pharmafocus_april_front_cover

The April 2017 edition of Pharmafocus is available to read online now!

March 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …

News
evatar

Replica reproductive tract could aid drug trials

March 29, 2017
Research and Development Woodruff lab

If most people were asked whether they had heard of a scandal in the pharmaceutical industry, the drug that would …

News
diabetes-777001_960_720

New drug therapy ‘reverses’ diabetes in mice

March 29, 2017
Research and Development diabetes

A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …

News
sanofi_regeneron

Breakthrough eczema drug given FDA approval

March 29, 2017
Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

News
nhs_bands

Cuts to prescriptions aims to save £128 million annually

March 28, 2017
Medical Communications, Research and Development NHS England, prescription

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

News
ludwig_hantson_small

Alexion leadership uncertainty ends as ex-Baxalta CEO steps in

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Appointment

Renowned scientist Owen N. Witte joins Kite Pharma Board of Directors

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026